Gastrointestinal disseminated histoplasmosis in HIV-infected patients: A descriptive and comparative study.


Journal

PLoS neglected tropical diseases
ISSN: 1935-2735
Titre abrégé: PLoS Negl Trop Dis
Pays: United States
ID NLM: 101291488

Informations de publication

Date de publication:
01 2021
Historique:
received: 31 08 2020
accepted: 08 12 2020
revised: 03 02 2021
pubmed: 23 1 2021
medline: 18 5 2021
entrez: 22 1 2021
Statut: epublish

Résumé

Disseminated histoplasmosis is one the main AIDS-defining opportunistic infections in HIV-infected patients, notably in Latin America. The non-specific and proteiform clinical presentation leads to diagnostic delays that may lead to fatal outcomes. This retrospective multicentric study aimed to describe the frequency and manifestations of gastrointestinal histoplasmosis in French Guiana, and to compare patients with disseminated histoplasmosis with or without gastrointestinal involvement. Between January 1, 1981 and October 1, 2014 co-infections with HIV and histoplasmosis were enrolled. Inclusion criteria were: age >18 years, confirmed HIV infection; first proven episode of histoplasmosis. Among 349 cases of disseminated histoplasmosis, 245 (70%) had a gastrointestinal presentation. Half of patients with gastrointestinal signs had abdominal pain or diarrhea, mostly watery. Half of patients with abdominal pain had diarrhea (63/124) and half of those with diarrhea (63/123) had abdominal pain. A significant proportion of patients also had hepatomegaly and, to a lesser degree, splenomegaly. After adjusting for potential confounding, the presence of lymphadenopathies >2cm (AOR = 0.2, IC95 = 0.04-0.7, P = 0.01), Haitian origin (AOR = 0.04, IC95 = 0.004-0.4, P = 0.006) were associated with a lower prevalence of gastrointestinal signs and positive gastrointestinal presence of H. capsulatum. Persons with a gastrointestinal H. capsulatum were more likely to have a decreased prothrombin time, lower ferritin, lower liver enzymes, and lower concentrations of LDH than those without gastrointestinal signs and symptoms. They also had a shorter interval between symptoms onset and diagnosis. Patients with a positive gastrointestinal identification of H. capsulatum were less likely to die at 1 month than those without a gastrointestinal presentation (respectively, 4.6% vs 18.5%, P = 0.01). Subacute or chronic gastrointestinal presentations are very frequent during disseminated histoplasmosis, they seem less severe, and should lead to suspect the diagnosis in endemic areas. There were populational or geographic differences in the frequency of gastrointestinal manifestations that could not be explained.

Identifiants

pubmed: 33481806
doi: 10.1371/journal.pntd.0009050
pii: PNTD-D-20-01556
pmc: PMC7857560
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0009050

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

PLoS Negl Trop Dis. 2020 Oct 19;14(10):e0008663
pubmed: 33075084
J Fungi (Basel). 2019 Dec 13;5(4):
pubmed: 31847076
J Fungi (Basel). 2019 Jun 17;5(2):
pubmed: 31212897
Mycoses. 2015 Mar;58(3):160-6
pubmed: 25641000
AIDS. 2008 May 31;22(9):1047-53
pubmed: 18520348
Am J Trop Med Hyg. 2014 Feb;90(2):216-23
pubmed: 24394475
PLoS One. 2020 Jul 24;15(7):e0236368
pubmed: 32706836
Ann Gastroenterol Hepatol (Paris). 1994 May-Jun;30(3):97-100
pubmed: 8067684
Rev Inst Med Trop Sao Paulo. 2012 Mar-Apr;54(2):89-93
pubmed: 22499422
Case Rep Gastroenterol. 2016 Nov 7;10(3):653-660
pubmed: 27920657
Clin Infect Dis. 2008 Jun 15;46(12):1813-21
pubmed: 18462102
Lancet Infect Dis. 2018 Oct;18(10):1150-1159
pubmed: 30146320
Am J Trop Med Hyg. 2011 Feb;84(2):239-40
pubmed: 21292891
Mycopathol Mycol Appl. 1967 Jul 13;32(2):153-62
pubmed: 6051844
Trop Med Int Health. 2007 Sep;12(9):1108-15
pubmed: 17875020
Clin Infect Dis. 1994 Aug;19 Suppl 1:S19-27
pubmed: 7948567
Enferm Infecc Microbiol Clin. 2004 Mar;22(3):156-9
pubmed: 14987536

Auteurs

Mathieu Nacher (M)

CIC INSERM 1424, Centre hospitalier Andree Rosemon Cayenne, Cayenne, French Guiana.
DFR Santé, Université de Guyane, Cayenne, Cayenne, French Guiana.

Audrey Valdes (A)

Equipe Opérationnelle d'hygiène hospitalière, Centre hospitalier Andree Rosemon Cayenne, Cayenne, French Guiana.

Antoine Adenis (A)

CIC INSERM 1424, Centre hospitalier Andree Rosemon Cayenne, Cayenne, French Guiana.
DFR Santé, Université de Guyane, Cayenne, Cayenne, French Guiana.

Romain Blaizot (R)

DFR Santé, Université de Guyane, Cayenne, Cayenne, French Guiana.
Department of dermatology, Centre hospitalier Andree Rosemon Cayenne, Cayenne, French Guiana.

Philippe Abboud (P)

Service des Maladies Infectieuses et Tropicales, Centre hospitalier Andree Rosemon Cayenne, Cayenne, French Guiana.

Magalie Demar (M)

Laboratory, Centre hospitalier Andree Rosemon Cayenne, Cayenne, French Guiana.
UMR Tropical Biome and Immunopathology, Université de Guyane, Cayenne, French Guiana.

Félix Djossou (F)

Service des Maladies Infectieuses et Tropicales, Centre hospitalier Andree Rosemon Cayenne, Cayenne, French Guiana.

Loïc Epelboin (L)

Service des Maladies Infectieuses et Tropicales, Centre hospitalier Andree Rosemon Cayenne, Cayenne, French Guiana.

Caroline Misslin (C)

Service de Médecine, Centre hospitalier de l'Ouest Guyanais, Saint Laurent du Maroni, French Guiana.

Balthazar Ntab (B)

Département d'Information Médicale, Centre hospitalier de l'Ouest Guyanais, Saint Laurent du Maroni, French Guiana.

Dominique Louvel (D)

Service de Médecine B, Gastroentérologie, Centre Hospitalier Andrée Rosemon, Cayenne, French Guiana.

Kinan Drak Alsibai (K)

Service d'Anatomopathologie, Centre Hospitalier Andrée Rosemon, Cayenne, French Guiana.

Pierre Couppié (P)

DFR Santé, Université de Guyane, Cayenne, Cayenne, French Guiana.
Department of dermatology, Centre hospitalier Andree Rosemon Cayenne, Cayenne, French Guiana.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH